[HTML][HTML] Equol, a metabolite of gut microbiota, attenuates liver steatosis via the SIRT1/HNF4α pathway in NAFLD mice
Z Luo, L Yang, J He, Y Han, X Rong, D Luo… - Journal of Functional …, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is a potentially severe liver disease that increases
evidence indicates that gut microbiota is related to it. In the study, 16S rRNA sequencing …
evidence indicates that gut microbiota is related to it. In the study, 16S rRNA sequencing …
Equol, a metabolite of gut microbiota, attenuates liver steatosis via the SIRT1/HNF4α pathway in NAFLD mice
Z Luo, L Yang, J He, Y Han, X Rong, D Luo… - Journal of Functional …, 2023 - agris.fao.org
Non-alcoholic fatty liver disease (NAFLD) is a potentially severe liver disease that increases
evidence indicates that gut microbiota is related to it. In the study, 16S rRNA sequencing …
evidence indicates that gut microbiota is related to it. In the study, 16S rRNA sequencing …
Equol, a metabolite of gut microbiota, attenuates liver steatosis via the SIRT1/HNF4α pathway in NAFLD mice.
Z Luo, L Yang, J He, Y Han, X Rong, D Luo, J Guo - 2023 - cabidigitallibrary.org
Non-alcoholic fatty liver disease (NAFLD) is a potentially severe liver disease that increases
evidence indicates that gut microbiota is related to it. In the study, 16S rRNA sequencing …
evidence indicates that gut microbiota is related to it. In the study, 16S rRNA sequencing …